| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $2.87B | $2.75B | $3.82B | $17.31B | $18.98B |
| Cost of Revenue | $641.80M | $541.30M | $599.80M | $3.00B | $2.91B |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $2.10B | $2.25B | $1.78B | $1.54B | $949.20M |
| SG&A | $514.40M | $531.10M | $495.00M | $484.70M | $285.80M |
| Operating Income | -$1.40B | -$1.31B | $690.40M | $12.64B | $15.28B |
| Interest Expense | $69.80M | $27.40M | $23.90M | $18.90M | $305.10M |
| Tax Expense | $85.30M | -$12.40M | $255.80M | $3.52B | $4.75B |
| Net Income | -$1.14B | -$665.30M | $930.30M | $9.43B | $10.29B |
| EPS (basic) | -4.7000 | -2.7700 | 3.8700 | 38.7800 | 42.1800 |
| EPS (diluted) | -4.7000 | -2.7700 | 3.8300 | 37.7700 | 39.6300 |
| Shares (diluted) | $241.70M | $240.40M | $242.70M | $249.80M | $259.70M |